(Q35195108)

7 August 2017

1 reference

title

Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not? (English)

1 reference

7 August 2017

0 references

Seibel MJ

1

1 reference

PubMed ID

12906376

7 August 2017

language of work or name

1 reference

1 May 2003

1 reference

Journal of Endocrinological Investigation

7 August 2017

1 reference

7 August 2017

26

1 reference

7 August 2017

464-471

1 reference

7 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03345204

7 August 2017

0 references

cites work

Molecular markers of bone turnover: biochemical, technical and analytical aspects.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Biochemical markers of bone turnover reflect femoral bone loss in elderly women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345204

Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

12 December 2020

Rapid bone loss is associated with increased levels of biochemical markers

1 reference

12 December 2020

Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: Results of a pilot study

1 reference

12 December 2020

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density

1 reference

12 December 2020

Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up)

1 reference

12 December 2020

Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density

1 reference

12 December 2020

The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation

1 reference

12 December 2020

Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345204

1 reference

7 August 2017

1 reference

PubMed ID

12906376